These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 21809248)

  • 1. [New concepts in the therapy of atrial fibrillation].
    Shin DI; Eckardt L
    Dtsch Med Wochenschr; 2011 Aug; 136(31-32):1587-90. PubMed ID: 21809248
    [No Abstract]   [Full Text] [Related]  

  • 2. 1:1 atrial flutter after vernakalant administration for atrial fibrillation cardioversion.
    de Riva-Silva M; Montero-Cabezas JM; Salgado-Aranda R; López-Gil M; Fontenla-Cerezuela A; Arribas-Ynsaurriaga F
    Rev Esp Cardiol (Engl Ed); 2012 Nov; 65(11):1062-4. PubMed ID: 22727797
    [No Abstract]   [Full Text] [Related]  

  • 3. Atrial fibrillation: epidemiology, prognosis and therapy.
    Rutzen-Lopez H; Khanna V; Reynolds MR
    Minerva Med; 2011 Jun; 102(3):187-207. PubMed ID: 21593721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion.
    Nagarakanti R; Ezekowitz MD; Oldgren J; Yang S; Chernick M; Aikens TH; Flaker G; Brugada J; Kamensky G; Parekh A; Reilly PA; Yusuf S; Connolly SJ
    Circulation; 2011 Jan; 123(2):131-6. PubMed ID: 21200007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment strategies atrial fibrillation].
    Lewalter T
    MMW Fortschr Med; 2014 Mar; 156 Spec No 1(1):49-52; quiz 53-4. PubMed ID: 24930348
    [No Abstract]   [Full Text] [Related]  

  • 6. Advances in the treatment of atrial fibrillation.
    Miranda RI; Simpson CS; Michael KA; Abdollah H; Baranchuk AM; Redfearn DP
    Minerva Cardioangiol; 2010 Dec; 58(6):637-48. PubMed ID: 21135805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [2010 AIAC Guidelines for the management and treatment of atrial fibrillation].
    Raviele A; Disertori M; Alboni P; Bertaglia E; Botto G; Brignole M; Cappato R; Capucci A; Del Greco M; De Ponti R; Di Biase M; Di Pasquale G; Gulizia M; Lombardi F; Themistoclakis S; Tritto M;
    G Ital Cardiol (Rome); 2011 Jan; 12(1 Suppl 1):7-69. PubMed ID: 22624161
    [No Abstract]   [Full Text] [Related]  

  • 8. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
    Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
    Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal intracerebral hemorrhage associated with administration of recombinant tissue plasminogen activator in a stroke patient on treatment with dabigatran.
    Casado Naranjo I; Portilla-Cuenca JC; Jiménez Caballero PE; Calle Escobar ML; Romero Sevilla RM
    Cerebrovasc Dis; 2011; 32(6):614-5. PubMed ID: 22133608
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of atrial fibrillation complications with antiarrhythmic drugs: still an unmet need in clinical practice.
    Dobrev D
    Expert Opin Pharmacother; 2011 Jun; 12(8):1195-1199. PubMed ID: 21548721
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparing the 2010 North American and European atrial fibrillation guidelines.
    Gillis AM; Skanes AC
    Can J Cardiol; 2011; 27(1):7-13. PubMed ID: 21329856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of atrial fibrillation].
    Hoffmann BA; Rostock T; Drewitz I; Steven D; Willems S
    MMW Fortschr Med; 2009 Nov; 151(47):58-62; quiz 63. PubMed ID: 20037981
    [No Abstract]   [Full Text] [Related]  

  • 13. Dabigatran for stroke prevention in all patients with atrial fibrillation?
    Hunchuck JE; Lake JD
    Pharmacotherapy; 2011 Aug; 31(8):725-8. PubMed ID: 21923597
    [No Abstract]   [Full Text] [Related]  

  • 14. [Paroxysmal atrial fibrillation].
    Lewalter T; Lüderitz B
    Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S8-9. PubMed ID: 10818996
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation.
    Shah SV; Gage BF
    Circulation; 2011 Jun; 123(22):2562-70. PubMed ID: 21606397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial fibrillation: preventing thromboembolism and choosing nondrug therapies.
    Chandramouli BV; Kotler MN
    Geriatrics; 1998 Jul; 53(7):53-60. PubMed ID: 9672497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vernakalant--a new drug for pharmacological conversion of atrial fibrillation].
    Hinneburg I
    Med Monatsschr Pharm; 2011 May; 34(5):154-8. PubMed ID: 21644373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expanded arsenal in atrial fibrillation: bye-bye marcumar?].
    MMW Fortschr Med; 2012 Jan; 154(1):20. PubMed ID: 22641998
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of atrial fibrillation - status quo].
    Straube F; Dorwarth U; Schmidt M; Hoffmann E
    Dtsch Med Wochenschr; 2012 Apr; 137(14):738-44. PubMed ID: 22454206
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of atrial fibrillation.
    Blaauw Y; Crijns HJ
    Heart; 2008 Oct; 94(10):1342-9. PubMed ID: 18801792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.